Theregen, Inc. Report issue

For profit Phase 1
Founded: San Francisco CA United States (2003)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2006
NCT00364390
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

anginera (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 1)

Heart Failure (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1